0001615219-20-000025.txt : 20200325 0001615219-20-000025.hdr.sgml : 20200325 20200325180221 ACCESSION NUMBER: 0001615219-20-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200323 FILED AS OF DATE: 20200325 DATE AS OF CHANGE: 20200325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arthur David J. CENTRAL INDEX KEY: 0001769331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 20743408 MAIL ADDRESS: STREET 1: 2450 HOLCOME BLVD. STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 4 1 wf-form4_158517372311926.xml FORM 4 X0306 4 2020-03-23 0 0001615219 Salarius Pharmaceuticals, Inc. SLRX 0001769331 Arthur David J. C/O SALARIUS PHARMACEUTICALS, INC. 2450 HOLCOME BLVD., SUITE J-608 HOUSTON TX 77021 1 1 0 0 Chief Executive Officer Stock Option (right to buy) 0.61 2020-03-23 4 A 0 60000 0 A 2030-03-22 Common Stock 60000.0 60000 D 25% of the options granted are fully vested on March 23, 2021, and quarterly vesting of the remaining options over 3 years. /s/ David J. Arthur 2020-03-25